Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma, T-Cell × Allopurinol × Clear all

Sponsor

Conditions

Lymphoma 5 Leukemia, Myeloid, Acute 5 Leukemia 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Tumor Lysis Syndrome 3 Myelodysplastic Syndromes 3 Burkitt Lymphoma 3 Lymphoma, Non-Hodgkin 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hyperuricemia 2 Congenital Abnormalities 2 Blast Crisis 2 Waldenstrom Macroglobulinemia 1 Sezary Syndrome 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1

Interventions

Cyclophosphamide 13 Etoposide 9 Prednisone 7 Peripheral Blood Stem Cell Transplantation 7 Doxorubicin 7 Brentuximab Vedotin 7 romidepsin 6 fludarabine phosphate 6 Whole-Body Irradiation 6 Vincristine 6 Melphalan 6 fludarabine 5 Rituximab 5 Mycophenolic Acid 5 Granulocyte Colony-Stimulating Factor 4 Gemcitabine 4 Busulfan 4 10-propargyl-10-deazaaminopterin 4 pembrolizumab 3 etoposide phosphate 3 Tacrolimus 3 Lenalidomide 3 Filgrastim 3 Cytarabine 3 Carmustine 3 Antilymphocyte Serum 3 thymoglobulin 2 prednylidene 2 deltacortene 2 carmustine, poliferprosan 20 drug combination 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡